ARVO heads north to Vancouver for 2019 annual meeting
April 5, 2019
‘From the Bench to Bedside and Back’ is focal point for this year’s conference
Recent Content
Laser’s place in diabetic retinopathy: Choosing the right scenario
April 1, 2019
When it comes to questions about the need for laser in diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR), the answers are “yes” and “no,” depending on the clinical scenario, said John Wells, MD.
Successful PDR outcomes driven by strict adherence to follow-up
April 1, 2019
Anti-vascular endothelial growth factor (VEGF) therapy is a viable alternative to panretinal photocoagulation (PRP) in eyes with proliferative diabetic retinopathy (PDR).
Look for clues to simplify anterior uveitis diagnosis
March 15, 2019
Though anterior uveitis is associated with myriad conditions, a relatively short list of disorders accounts for the vast majority of cases.
Read-through, gene therapies for LCA showing promise
March 8, 2019
Group of researchers aim to validate both approaches in proof-of-concept study
Ongoing study evaluates sirolimus as therapeutic option for uveitis
March 8, 2019
Inhibition plays role in autoimmune-based inflammation; has unique mechanism of action
Tocilizumab effective for managing posterior segment inflammation
March 7, 2019
Improvement in visual acuity, central retinal thickness, vitreous haze reported at 6 months
Sustained-release corticosteroid expands armamentarium for uveitis
March 7, 2019
FA implant effective in lowering recurrence rates through available 6, 12 months of follow-up
Adalimumab efficacious for uveitis regardless of disease duration
March 7, 2019
Quiescence, steroid-free quiescence achieved in VISUAL III trial
